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resumo 
 
 
Ao longo da última década, o processo de auto-montagem peptídica têm 
suscitado considerável interesse pela sua capacidade de gerar novos 
biomateriais com diversas aplicações, incluindo a regeneração de tecidos e 
cosméticos. Biomateriais com base peptídica são agrupados de baixo para 
cima a partir de pequenos blocos de construção. O presente estudo concentra-
se na utilização de diferentes motivos estruturais peptídicos para a construção 
de biomateriais fibrosos. Neste trabalho, diferentes péptidos amfifílicos foram 
sintetizados utilizando o processo de síntese peptídica do estado sólido para 
formar distintas estruturais peptídicas. A capacidade de auto-montagem e 
propriedades biológicos foram caracterizados utilizando dicroismo circular, 
espectroscopia, microscopia electrónica de transmissão  e determinada a 
concentração mínima  inibitória. Os espectros de dicroísmo circular revelaram 
bobina aleatória e conformações β-folha para as estruturas amfifílicas. A 
maioria das imagens de TEM revelou estruturas fibrais à nanoescala e foi 
observada alguma atividade antimicrobiana. Efetivamente, os resultados 
demonstram que os péptidos sintetizados possuem capacidades de auto-
montagem para formarem supraestruturas nanofibras, não revelando no 
entanto fortes propriedades antimicrobianas. Este trabalho apresenta novos 
designs de biomateriais com potenciais aplicações em reparação de tecidos 
através da capacidade de formação de nanofibras  
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abstract 
 
Over the last decade self-assembling peptide systems have attracted 
considerable interest as novel biomaterials for use in different applications 
including tissue regeneration and cosmetics. Peptide-based biomaterials are 
assembled from small building blocks from the bottom up. This study is focused 
on the use of different peptide folding motifs as building blocks for the 
construction of fibrous biomaterials. Different peptide amphiphiles (PAs) were 
synthesized using solid phase synthesis and their folding, self-assembly and 
biological properties were characterized using circular dichroism (CD) 
spectroscopy, transmission electron microscopy (TEM) and minimal inhibitory 
concentration (MIC) assays. CD spectra showed random coil and β-sheet 
conformations for the amphiphiles. TEM revealed nanoscale fibre structures for 
most of the PA’s, some of which displayed antimicrobial activity. Effectively, the 
results demonstrate that the designed peptide self-assembles into nanofibre 
suprastructures. However, the peptides were not strongly antimicrobial and 
formed fibrillar structures. This work introduces new biomaterial designs with 
potential applications as nanofibre scaffolds for tissue engineering.  
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Chapter 1 - Introduction 
 
1.1 - Biomaterials  
 
In 1976, the European Society for Biomaterials (ESE) defined a biomaterial as 
“a nonviable material used in a medical device, intended to interact with biological 
systems” (1, 2 ). However, the current definition put forward for a biomaterial is “a 
material intended to interface with biological systems to evaluate, treat, augment or 
replace any tissue, organ or function of the body (3 ,4). Biomaterials have been 
investigated because of their many potential biological functions, such as releasing 
polypeptide growth factors, blocking antibody permeation and serving as matrices to 
guide tissue regeneration (3,5).  
Biomaterials have become a promising area of research with successful 
applications in medicine and bioengineering (6). Different chemical systems have 
been developed as biomaterials, including synthetic polymers, and recently, 
molecular design based on biological structure. Polymeric biomaterials with 
inorganic systems have been used in tissue engineering, particularly in orthopaedic 
research (7). Hydrogels differ from most biomaterials as they do not dissolve in 
water and have also found use for biomedical applications (3).  
 
 
1.2  - Peptide-based biomaterials  
Complementary strategies can be used in the fabrication of molecular 
biomaterials. These materials can be generated by stripping down or molecule-by-
molecule assembly (5, 6). However, molecular self-assembly is considered to be the 
most powerful approach in the fabrication of novel materials. Peptides self-organize 
to form a distinct structure with a specific functionality (8). For this reason, this 
process has been exploited for the production of synthetic material where proteins 
are versatile building blocks for fabricating materials. 
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Much research has been focused on self-assembling peptides that produce 
supramolecular structures with very distinct features. Different structural motifs can 
be used as self-assembling building blocks. For example, α-helix, β-sheet, collagen 
and amphiphilic peptides have been shown to give different supramolecular 
morphologies (Figure 1.1). Other examples include ionic self-complementary 
peptides, which is a type of surfactant-like peptide, surface nano-coating peptides 
and molecular switches (6).  All these structures can be cross-linked together to form 
fibrous structures. 
 
 
α-helical 
structure 
β-structure Collagen  
Structure 
Amphiphilic 
structure 
   
 
 
Figure 1.1: Examples of protein structural motifs, schematics (top) and transmission electron 
micrographs (bottom) (6).   
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Biomaterials play an important role in many activities, for example, as matrices to 
guide tissue repair, and in the stimulation of a vascularization response releasing growth 
factors (9). In the future biomaterials will assume an important role in medicine and be 
used in a wide variety of non-medical applications through biological design and the 
incorporation of dynamic behaviour (10). For these reasons the study of these peptide-
based materials is a promising field of research and of interest for use in the fabrication of 
different materials for a wide range of applications. 
 
1.3 – Peptide self-assembly 
 
1.3.1- Features of peptides used as building blocks 
 
The molecular arrangement of peptide materials has been investigated over 
the past years (10). Their molecular structures may be constituted by biological, 
organic and/or inorganic compounds (10). For this reason, understanding molecular 
structure is a crucial step when building a new biomaterial. 
Self-assembly is a process in which biological entities (building blocks) are 
spontaneously organized to form a supramolecular structure (11, 12). However, this 
mechanism displays special interactions that enable the construction of a novel 
material (13). The driving forces of molecular self-assembling are non-covalent 
interactions, such as hydrophobic, ionic, Van der Walls forces and hydrogen bonds, 
which are essential for the specific association between different building blocks. 
Among the building blocks used are short peptides (12).   
Peptides are polymers of α-amino acids connected through peptide bond 
(amide bond) (Figure 1.2b) (8). The bond formation occurs between the carboxyl and 
the amide group present in all natural amino acids. An amide bond is formed 
between two amino acids through the release of a water molecule where the α-carbon 
is a chiral centre asymmetric (Figure 1.2a) (8). What characterizes each of these 
molecules is the variable group R side chain, which provides different properties and 
biological functions. In nature there are 20 amino acids. These are divided into polar 
and non-polar structures, as well as according to charge (positive or negative) (8).  
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a) 
 
b)  
 
 
 
Figure 1.2: a) Schematic representation of amino acids. R is the side chain specific to each amino 
acids (2) b)Peptide bond (amide bond) between two amino acids (2). The amide bond is a chemical 
covalent bond that results from the reaction between the carboxyl group of an amino acid and the 
amine group of another.   
 
  
1.3.2- Protein folding motifs 
 
1.3.2.1 –α-helix and β-sheet 
 
The mechanism by which the protein folds to form different structures is not yet 
fully understood (14, 15). Knowing how the amino acid sequence interacts to form a 
3-D structure is a crucial to understanding their contribution to the protein folding 
process (16) There are two main folding motifs in proteins: α-helices and β- sheets 
(17).  
The α-helix structure is characterized by hydrogen bonds between the N-H 
group of an amino acid (α) and its C=O group (i +4, i+7), as seen in figure 1.3. 
Generically, it could be described as the coiling of the amino acid sequence around a 
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virtual axis. Experimental measurements indicated a periodicity of 3.6 amino acids 
per helical turn (figure 3) (18).  
a) b) 
 
 
                  
Figure 1.3: a) Structure of α-helix display the hydrogen bond between N-H group and CO group. 
Representation of 3.6 residues per turn (3) . b) Model protein classes (16). 
 
The β-sheet structure consists of different β-strands laterally connected by 
hydrogen bonds between their NH and C=O groups along the peptide/protein 
backbone- (19). The type of arrangement and relationship between the sequential 
strands is defined by hydrogen bonds. In a parallel arrangement, all strands are 
oriented in the same direction (Figure 1.4). However, when the orientation of the 
strands is opposite an antiparallel β sheet is formed (Figure 1.4) (19). The torsion 
angles that β-sheet can adopt depend on the type of the side chain formed by amino 
acid residues.  
The formation of parallel β sheet in protein aggregation is associated with some 
neurodegenerative diseases like Alzheimer’s, Parkinson’s and prior disease (19, 20). 
Many researchers have sought to understand the factors that lead to amyloid 
formations, such as protein sequence and environment conditions. Other studies have 
focused their investigation on the variety of β-sheets that derive from amyloid 
protein (21).  
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Figure 1.4: Structures of parallel and anti parallel β-sheet which show the difference in hydrogen bond 
patterns. (19)  
 
The secondary structure of peptide molecules has gained considerable interest 
among researchers who work in the field of self-assembly (21). The β-sheet can be a 
fundamental element of a building block for nanomaterials using proteins (22). 
Consequently, the importance of this secondary structure is currently being 
investigated due to its potential for the development of a new structure design for 
various applications. Lorraine et al studied four peptides and have proposed designs 
that bring about the formation of β-sheet at the air-water interface (23).  They 
quantified the intermolecular interactions that take place between phase behaviours, 
which allowed these researchers to explore the relationship of self-assembly and its 
role in the production of composite biomaterials (23).    
Matthew et al, on the other hand, have designed a new peptide with two β-sheets 
containing hydrophobic valine and hydrophilic lysine residues in alternation (14). 
The central sequence contains diproline translated as Pro-Pro, which opens up 
conformation and supports trans linkage. The 
D
Pro-
L
Pro sequence undergoes 
intermolecular folding and adopts a β-hairpin conformation, which self-assembles as 
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β-sheet-rich hydrogels. Contrarily, peptide with an LPro-LPro sequence adopts an 
extended β-strand and self-assembles as amyloid fibril. Figure 1.5 shows both folded 
peptides along the fibril axis translated as formation of intermolecular β-sheet 
hydrogen and extended β-strand. These structures exhibit characteristics similar to 
those of amyloid fibril, which, when assembled, are stable at different Ph levels and 
temperatures (14).  
 
 
Figure 1.5: The peptide sequence and self-assembled material. Peptides with 
D
Pro-
LPro adopt β-
hairpin conformation and TEM revealed entangled fibrils with a widhth of 3 nm each. Peptides with 
L
Pro-
L
Pro adopted extended β-strand conformation and TEM revealed fibrils (14).  
 
 
1.3.2.2 – Collagen 
 
Collagen, which exhibits very characteristic folding, is the most prevalent 
protein in the animal kingdom (24). This protein is located at diverse sites with 
specific functions, playing a key role in maintaining tissue and cellular size and 
shape (25). Because of this key structural feature, collagens have acquired significant 
interest within the scientific community (26).    
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The structure of collagen was determined by X-Ray diffraction over 50 years 
ago. It is characterized by a triple helix with three different polypeptide chains (α-
helix) that are combined to fold together to the left (27,29). Amino acid composition 
consists of a repeated tripeptide with a X Y Gly sequence, in which Proline (Pro) and 
hydroxyproline (Hyp) are predominant in the X and Y positions, respectively (Figure 
1.6) (28, 30). The latter amino acids (Pro and Hyp) help to stabilize the triple helix, 
while glycine (Gly) facilitates hydrogen bonding and intermolecular cross-link.  
         
 
a) b) 
  
Figure 1.6: a ) Molecular structure of collagen - like peptide (Ac-Pro-Hyp-Gly-HH3) triple helix (28). b) 
The molecular surface (28)   
 
The collagen self-assembly has not been fully understood, but several methods 
describe this process like a periodic fibrilar assembly (31).  Some studies have 
indicated that fibers consist in building blocks with periodicities (29). Three peptide 
chains forming the triple helical collagen molecule of 294, 8 nm in length and 1,5 nm 
in diameter (24). Hydrophobic and electrostatic interactions are involved in the 
arrangement of the collagen monomers where several molecules form a microfibril. 
These microfibrils have been suggested that to be the building blocks of fibril with a 
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67 nm (D-period) periodicity axial (24). The figure 1.7 shows the hierarchical 
organization of collagen. 
 
 
Figure 1.7: Structural Hierarchy of Collagen (29).  
 
 
Nearly 30 types of collagen proteins were identified and described with different 
structures, organization and localization (30). These are characterized by a complex 
structure, splice variants, self-assembly ability and several biological functionalities. 
Collagen can be classified as fibril-forming collagens, microfibrillar collagens, 
anchoring fibrils, hexagonal network forming collagens, fibril associated collagens 
(FACIT), transmembrane collagens and multiplexins (31).  
Rele et al have described the solid phase synthesis of collagen-mimetic triple 
helix peptide promoters (32). According to these authors, the primary sequence 
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comprises three different X Y Gly domains, where  the Pro-Hyp-Gly central core is 
flanked with Glu ( negative charged) or Arg ( positive charged) peptide repetition 
(Figure 1.8a).  The presence of strong electrostatic and hydrogen bonds between 
staggered positions allows the formation of thermodynamic stable complexes (Figure 
8b).  
 
  
a) 
 
b)  
 
 
Figure 1.8:  a) Amino acid sequence of collagen-mimetic peptide indicating the distinct domains found 
in its structure. b)  Interhelical electrostatic interactions yielding triple-helical protomers (32). 
 
 
Figure 1.9 shows a Transmission Electron Microscopy (TEM) image of a synthetic 
peptide which was self-assembled into a periodic fibrous structure. After a long period 
of incubation the formation of ~70 nm diameter uniform micron-length fibres was 
observed. The capacity to design periodic elements into reliable assemblies can 
facilitate fabrication and tailored ordered materials for several applications.  
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Figure 1.9: High magnification transmission electron micrographs reveal a well defined periodic 
structure (32). 
 
 
1.4– α-helix and coiled coil–based biomaterials 
 
In reality, the coiled coils domain is present in several proteins that play important 
biological functions. The examples of these proteins are transcription factors, muscle 
myosin, tumour suppressors and cytoskeleton proteins. For this reason, coiled coil 
domains have attracted special interest for use in the design of new synthetic peptides. 
 
1.4.1 –Design principles 
 
The coiled coil structure was originally observed in native proteins (33). This 
structure consists of two or more α-helixes that are wound into a superhelix (34, 35).  
Coiled coil is characterized by the distance of a full-turn of the superhelix (“pitch”),  
by the angle between the helix and its axis (“pitch angle”) and the angle between two 
neighbouring helices (“helix-crossing angle”) (36). Figure 1.10 shows the global 
parameters of a coiled-coil. 
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Figure 1.10: Global parameters of a coiled-coil structure [37]. 
 
Usually α-helix requires 3.6 amino acids per turn. However, a coiled coil helix 
shifts to the left and accommodates 3.5 residues per turn (18). This allows the 
repetition of side chains after every sequence of seven residues. The design of coiled 
coil peptides is based on heptad repeats. The heptad amino acids are also named 
abcdefg, where a and d are hydrophobic, e and g are positions often occupied by 
charged amino acids, and the remaining amino acids are generally hydrophilic 
residues (35, 36). Hydrophobic residues have an important role in structure stability 
during the self-assembly process, forming the helix interface, while the amino acids 
in e and g positions allow electrostatic recognition (33).  
The α-helices can be combined to form parallel or antiparallel homodimers or 
heterodimers. (34). The orientation of coiled coil helices is determined by the 
interaction between the two heptads residues (33). Figure 1.11 shows amino acid 
repetition and illustrates the two different orientations that can be found between α-
helix in a coiled coil. In a parallel coiled coil the residues in d position of one α-helix 
interacts with the amino acids of the neighbouring α-helix in the same position. (37). 
On the other hand, in a antiparallel coiled coil the α-helix runs in the opposite 
direction to that of a parallel coiled coil, which means that the residues found at d 
position interact with the amino acid found at a position. These different orientations 
have been exploited to design several synthetic peptides.  
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a) b) 
 
 
Figure 1.11: Schematic side view representations of two–stranded parallel and antiparallel coiled coils. 
The residues of one helix are labelled a-g, while those of the other helix are marked a`- g`.                                 
a) Illustration of a parallel coiled coil showing both N termini. Potential interactions between g´ and e 
residues are indicated. b) Representation of an antiparallel coiled coil where the N termini is shown on 
the left and C terminus on the right. Potential interaction between g` and g residues (38). 
 
1.4.2. – Assemblies based on coiled-coil 
 
 
The success in the development of novel designed molecules from 
spontaneously peptide-based building blocks has motivated further research in 
molecular design. The design of a coiled coil covers every type of structure from 
parallel and antiparallel homodimers to parallel and antiparallel heterodimers (39). 
Most peptides with self-assembly capacity described in literature use a solid phase 
peptide synthesis technique as it is very efficient (40, 41). In light of this, some 
researchers have sought to design α-helix coiled coil with the ability to grow and 
form fibrous aggregates (42, 43). 
Many works suggest that α-helix coiled coil plays an important role in the 
promotion of peptide self-assembly. Woolfson and co-workers described peptides 
based on parallel folding of a coiled coil, which allows for the understanding of the 
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design principles of self-assembly in peptide systems (36, 39). The peptides the 
authors investigated consisted of heptad repeats with isoleucine and leucine in 
hydrophobic positions a and d, respectively. The research group introduced 
glutamates and lysines in g and d positions to allow the occurrence of ionic 
interactions. (Figure1.12). The resulting fibres were straight, rod-shaped and micro in 
length.  
 
 
 
Figure 1.12:  Dimeric coiled coil heptad with specific residues at g, a, d and e positions (36).  
 
 
Dong et al described four coiled coil peptides which are differentiated by the 
amino acids found at b, c and f positions (44). These particular amino acids were 
selected with the aim to form a dimeric coiled coil. The researchers demonstrated 
that nanofibres are formed when the concentration of a peptide increases. In addition, 
they observed that introduction of positive charge residues at b, c and f positions 
results in the appearance of nanofibres with diameters of 4 nm. On the other hand, in 
the absence of positive charge residues self-assembly created fibres 20 or more 
nanometres in diameter. This observation led to the creation of an alternative 
mechanism for self-assembly. 
In previous works Woolfson et al introduced the concept of self-assembling 
fibres (SAF)(45). This system comprises a design with two complementary de novo 
leucine-zipper peptides that form a sticky ended heterodimer (46). Each peptide is 28 
residues-long that assemble and mix to form fibres. The mature SAF samples were 
 15 
prepared with a mixture of SAF-p1 and SAF-p2 (39). The primary sequence of these 
is characterized by heptad repeat, HPPHPPP, where H is hydrophobic and P polar 
residues. Ryadnov et al applied the SAF concept to produce heterodimers in a 
parallel coiled coil (47). SAF peptides have different subunits, namely A and B 
domains in SAF-p1 and C and D regions in SAF-p2. Thus, A and D regions 
complement each other, whilst B is complementary to C (Figure 1.13b). In this 
investigation, SAF-p2 was re-designed as SAF-p2a because the latter interacted 
better and more efficiently with SAF-p1 (see Figure 1.13a). This combination 
improved affinity between the two protofibrils, and resulted in the formation of 
straight fibrils, as shown in Figure 1.15a.  
 
a 
 
b 
 
 
 
 
 
 
 
Figure 1.13: a) The peptide sequence of SAF-p1 and SAF-p2a comprised of two blocks each. A and B 
blocks for SAF-p1 and C and D blocks for SAF-p2a. b ) B complements C and A complements D. This 
connection results in a sticky-ended dimer (47). 
 
Another alternative explored by the authors was the introduction of discontinuities into 
the SAFs fibres, which brought about kinks and splits in the two new peptides CC 
NN
 
and DD 
CC
, respectively. The CC
NN
 peptide is comprised of two copies of block C 
linked by the C-termini, while both N-termini remain free. This enabled the interaction 
between the two blocks. However, the two copies of C blocks are joined by β-alanine to 
give flexibility to the peptide structure. The DD
CC
 peptide follows a similar principle: 
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two copies of D blocks are linked via N-termini while C-termini remain free. Figure 
1.14 schematically shows the conception of both peptides. Due to differences in their 
sequence blocks, fibres with distinct characteristics were observed (Figure 1.15). 
 
a) b) 
  
 
Figure 1.14: The discontinuous design of a) CC
NN
 and b) DD
CC
 peptide. β-alanine causes a kinked 
structure rather than a straight one because of the flexibility induced by this residue (47). 
 
a)  
 
b) 
 
c) 
 
Figure 1.15: TEM of: a) Straight fibres formed between SAF-p1 and SAF-p2a in 1:1 ratio. b) Fibres 
formed by adding CC
NN
 peptide to SAF-p1/SAF-p2a in 1:1:1 ratio. c) Fibres formed by adding DD
CC 
peptide to SAFp1/SAF-p2a in 0,01:1:1 ratio (47). 
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1.5- Peptide-Amphiphile  
 
 
Amphiphilic molecules are constituted by distinct hydrophobic and hydrophilic 
segments (48). This structure consists of a peptide attached to a hydrophobic alkyl 
tail. Aliphatic tails in an aqueous solution tend to aggregate, while the peptide 
portion packs on the surface. It is well known that self-assembly leads to the 
formation of nanofibres with a structure similar to that of cylindrical micelles (49). 
This formation is possible due to a number of interactions like dipole-dipole, 
hydrogen bond, nonspecific van der Walls interaction and hydrophobic force.  
Self-assembly of peptide-amphiphile (PA) has raised interest in scaffolding of 
new biomaterials for many applications (50). Self-assembled PA can adopt various 
morphologies by choosing different residues and alkanes. Stupp et al have designed a 
peptide-amphiphile with a hydrophobic tail and a hydrophilic peptide head (Figure 
1.16) (51). This peptide was synthesized by standard solid phase chemistry according 
to the following specific features: 1) four cysteine amino acids were incorporated to 
form disulfide bonds between adjacent molecules. 2) the serine was phosphorylated 
at the peptide end to attract calcium and other ions, and to regulate and facilitate the 
mineralization of hydroxypatite. 3) Arg-Gly-Asp (RGD) sequence was introduced 
into the peptide to promote cell attachment to the nanofibres. The last of these 
characteristics would be beneficial for biomedical applications. TEM imaging 
suggests that assembled peptide-amphiphile forms nanofibres and is stable in an 
alkaline solution (Figure 1.17).  
 
 18 
 
 
 
Figure 1.16: Chemical structure of peptide-amphiphile. Region 1 is a hydrophobic segment with 16 
carbons. Region 2 consists of four consecutive cysteines. Region 3 is a flexible linker with 3 glycines. 
Region 4 is a single phosphorylated serine. Region 5 shows the cell adhesion ligand ( RGD) (51). 
 
 
Figure 1.17:Self-assembly of PA in the form of a cylindrical micelle (51). 
 
Later Hartgerink and co-workers reported a prototypic peptide amphiphile 
containing 12 amino acids and an alkyl tail with 16 carbons (52). The importance of 
hydrogen bonds in self-assembly was investigated through a set of 26 PA’s, 
including 19 N-methylated variants and 7 alanine mutants. PA1 has a linker region 
(seven glycines) connecting the hydrophobic segment to the head group, which 
consists of Glu-Arg-Gly-Asp-Ser (ERGDS) sequence (Figure 1.18). The remaining 
PA consists of peptides with alanine mutations.  
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Figure 1.18: Sequence of PA1. The molecule includes a hydrophobic region (C16), a glycine region and 
a charged head group (52).  
 
 
 
These peptides displaying alanine mutations were analyzed by circular dichroism 
(CD), Fourier transform infrared spectroscopy (FT-IR) and TEM. It was found that 
the four amino acids close to the core are critical for self-assembly of PAs into 
nanofibres. For this reason, by selectively eliminating the key hydrogen it is possible 
to change the nanostructure resulting from self-assembly. Thus, this study helps to 
understand the self-assembly mechanism of peptide-amphiphile.  
 
 
 
 
Figure 1.19: a) Cryo-TEM Images of PA1. This peptide-amphiphile forms nanofibres.  
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1.6 - Aim and objectives 
 
 
Biomaterials have led to great improvements in many applications due to their 
specific characteristics. The aim of the present work is to fabricate a new biomaterial 
with capacity to self-assemble by synthesizing and characterizing a new peptide with 
different folding.  
 
The specific objectives of this work are: 
 
1. Design and synthesis of a new peptide with different folding using the 
solid phase peptide synthesis method; 
2. Purification using High Performance Liquid Chromatography (HPLC); 
3. Biophysical characterization of generated models in aqueous and 
membrane environments and analysis by circular dichroism (CD)  
4. The use of electron transmission microscopy (TEM) to confirm the 
presence of nanofibres. 
5. To investigate the interactions of the synthesised constructs with bacteria  
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Chapter 2 - Methods and Materials  
2.1-Solid Phase Peptide Synthesis 
Solid Phase Peptide Synthesis (SPPS) as conceived and demonstrated by 
Merrifield can provide oligopeptides and small proteins (53, 54). The strategy is 
based on the use of amino acid side chain protection and the attachment of a C-
terminal amino acid to an insoluble polymeric support (i.e. solid) via a linker (55). 
Side chains that may be reactive and an α-amino group are protected with temporary 
protecting groups to avoid them reacting with each other (56). The process starts 
with the coupling of the first amino acid to the resin followed by the deprotection of 
the α-amino protecting group. After this a second protected amino acid can be 
introduced in the growing sequence. This cycle is repeated until the required peptide 
sequence is assembled. At the end of the synthesis, the protecting groups are 
removed and the bond between the C-terminal amino acid and the polymeric support 
is cleaved with a specific reagent (56). Figure 2.1 shows the scheme of solid phase 
peptide synthesis.  
 
Figure 2.2: Solid Phase Peptide Synthesis. The green square is a temporary protecting group of an 
amino group, X, Y and Z are side chains and the red circle depicts a side chain protecting group (53).  
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The main advantage of this method is that there are only two reactions, the 
amide bond formation and deprotection.  These require optimization and the use of 
excess solvents and reagents, as well as the removal of by-products by simple 
washing (53,57). On the other hand, SPPS has its limitations, namely the number of 
peptides achievable is restricted (maximum 50 amino acids) and the fact that the 
method implies the use of a large quantity of expensive solvents (53).   
 
 
2.1.1 – Solid Support 
 
Different solid supports have been developed over time. The resins normally 
used as supports are polyethylene glycol polyacrylamide copolymer (PEGA) resin, 
cross-linked ethoxylate acrylate resin (CLEAR), polyamide resin and polyethylene 
glycol (PEG) (58). However, of these the most widely used in solid phase synthesis 
is a cross-linked polymeric resin obtained from the  co-polymerization of styrene and 
divinylbenzene (DVB) (figure 2.2)(58). Polystyrene is a co-polymer of linear vinyl 
benzene.  
 
 
 
 
 
Figure 3.2: Occurrence of polymerization between styrene and DVB (59). 
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The quantity of divinylbenzene used for cross-linking is about 1-2% (56). 
Consequently, this resin has an increased hydrophobicity that can affect the peptide 
assembly (57).  
 
2.1.2 – Linkers 
 
The choice of linkers depends on the synthesis method used, hence the 
development of a large number of linkers. Linkers in solid phase synthesis provide 
an anchor point on the solid support. During peptide synthesis the linker should be 
stable (60). Among the several linkers used in SPPS, Wang resin is one of the most 
popular. This is a Merrifield resin with a Wang linker, which results from the 
reaction between p-hydroxybenzyl and methyl-4-hydroybenzoate (61). After 
coupling, this intermediate is reduced in the ester group by LiAIH4 (61), and at the 
end of the synthesis the resin is treated in acidic conditions with 95%TFA 
(trifluoroacetic acid) to cleave the ester linked (60, 61).  
MBHA (methylbenzhydrlamnine) resin is used in the synthesis of peptide 
amides (62). This resin is prepared from N-[(benzotriazol-1-yl)(p-
tolyl)methyl]formamide or N-[formamido(p-tolyl)methyl]formamide as shown in the 
figure 2.3(57, 62). Upon completion of synthesis, the peptide is cleaved from the 
resin by 95%TFA.  
 
 
 
 
Figure2.4: Synthesis of MBHA resin (62) 
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2.1.3 – Fmoc and Boc strategy in solid phase peptide synthesis 
 
 In amino acids the side chain group, R, defines their structure and properties. 
Side chains in amino acids can be reactive and may interfere with the formation of 
the amide bond if not protected. For this reason, protecting groups are necessary for a 
side chain and an α-amino protection group (56). Fmoc (9H-fluoren-9-
ylmethoxycarbonyl) and Boc (tert-butyolxycarbonyl) are two different α-amino 
protecting groups used in SPPS (56). The choice between Fmoc or Boc depends on 
the nature of the resin (53, 56). In Fmoc peptide synthesis basic conditions are used 
to remove the α-amino protecting group after each coupling, but the side chain 
protecting groups are removed in acidic conditions at the end of the synthesis 
simultaneously with the cleavage of the resin (56).   
 The Boc protecting group is removed using strong acids such as TFA. As 
shown in figure 2.4, tert-butyl carbonium ions are formed during deprotection (57). 
Fmoc is a base labile group and is removed under strong basic conditions typically 
using piperidine. 
 
 
  
  
 
 
 
 
 
 
 
 
Figure2.5: Deprotection process using TFA (57) 
 25 
2.1.4 – Coupling methods 
 
 In SPPS the carboxyl group of amino acids needs to be activated  by reagents, 
for example, cyclohexylcarbodiimide (DCC) (57). Hydroxybenzotriazole (HOBt) is a 
common additive used in combination with carbodiimides for amide bond formation 
(1). However, a HOBt derivative HOAt( 1-hydroxy-7-azabenzotriazole) has been 
shown to give better results as it is more reactive and reduces recemization (57, 63). 
Uronium and phosphonium salts have been described as excellent reagents. HBTU 
and TBTU belong to the uronium salt group, whereas PyBOP and BOP are 
phosphonium salts (57). However, the most popular coupling reagents are HBTU and 
TBTU, which are differentiated only by counterions - PF6 
–
 and BF4 
– 
, respectively. 
Figure 2.5 depicts the structures of different coupling reagents.  
 
 
  
HOBt HOAt 
 
HBTU/TBTU  
  
Figure 2.5: Hydroxybenzotriazole and derivative additive (top) and uronium salts (below) (63) 
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2.2 – Characterization of crude peptides  
 
2.2.1 - Coupling High Performance Liquid Chromatography (HPLC) to a 
Mass Spectrometer (MS) 
 
 Chromatographic techniques, such as High Performance Liquid 
Chromatography (HPLC), are used to separate a mixture of compounds that are 
dissolved in a solution, whilst Reverse Phase (RP) HPLC is the most common 
method used for peptide purification (64, 65). This technique has a hydrophobic 
stationary phase and a hydrophilic mobile phase. In general, the column supports are 
composed of hydrocarbon alkane chains attached to silica (stationary phase) and the 
polar solvent is used in a mixture of water and an alcohol (mobile phase)(65). In this 
method, when a peptide solution passes through the column, a strong interaction 
occurs between the hydrophobic phase and apolar molecules in solvents. The 
attraction between stationary phase and polar molecules is low (64), while 
hydrophobic molecules in solution tend to form Van der Walls interactions with the 
stationary phase (65). Thus, the polar molecules will move through the column faster 
than non-polar molecules.  
 Mass Spectrometry (MS) is a powerful analytical tool (66, 67). Matrix-assited 
laser desorption ionization (MALDI) is one of the most commom ionization 
methods. This soft ionization technique uses a laser beam to convert biomolecules 
into gas phase ions that are then accelerated by an electric field and separated 
according to their mass-to-charge ratio (m/z) (68). The gas-phase ions are generated 
from a solid matrix mixture by laser, causing the vaporization of the analyte (67, 69). 
MALDI has the advantage of producing singly charged peptide ions, hence 
minimizing spectral complexity (67). When the mass is measured using the time of 
flight of the ions in a drift tube, the analyzer is called time of flight (ToF) (70).  
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ToF analysers can be operated in linear and reflectron modes (70). Figure 2.6 
shows an MS apparatus where a MALDI source has been coupled with a ToF 
reflectron analyser. 
 
 
 
Figure 2.6: MALDi with TOF reflectron(70). 
 
 
Mass spectrometers can be coupled with separation techniques such as LC. This 
approach can be used when previous separation of the analytes is necessary, and 
allows better sensitivity in the identification of the components of a mixture. (67).  
 
2.2.2 – Circular Dichroism (CD)  
  
 Circular Dichroism (CD) spectroscopy is a technique used to determine the 
folding of peptides and proteins(71). This method provides important information 
pertaining to biomolecular conformation and is based on the different absorption of 
left and right circularly polarised light (ΔA =ALeft – ARight)(72). This effect occurs by 
chiral chromophore or placed in an asymmetric environment (71).  
 CD instrumentation uses a source of light with two different wavelengths. The 
monochromator selects the wavelength that crosses the polarizer and forms a plane-
polarised and two distinct circularly polarised components. The latter pass through 
the modulator containing an alternating electric field, as shown in figure 2.7 (72).  
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This induces structural changes which make the plate transmit circularly polarised 
light (72, 73). The addition of AR and AL absorbance vectors results in radiation 
designed to be elliptically polarised (73). In the spectra information obtained the 
concentration of the peptide can be multiplied by the mean residue weight and the 
peptide mass can then be divided by the number of peptide bonds. This operation 
will then be expressed as molar ellipticity, deg cm
2
dmol
-1
 (73). 
 
 
Figure 2.7: CD instrumentation  
 
CD spectroscopy operates in far UV (260-160 nm), where it is possible to 
observe the contributions of the peptide bond to the change in polarised light, and also 
near UV (320-260 nm), where aromatic residues can be detected (71). Far UV CD is 
generally reported in efforts to gain an understanding of protein secondary structure (α-
helix, β- sheet, β-turn and unordered content) (72). The different protein foldings put 
forward thus far have specific CD spectra (71). Hence, α- helix is characterized by 
negative bands at 222 nm and 208 nm and by a positive band at 190 nm (71). Proteins 
with β-sheet structure have negative bands at 216 nm and a positive band at 196 
nm(71). The random coil structure is characterized by a negative band at 198 nm and a 
positive band at 219 nm (71). Figure 2.8 shows typical spectra for different structures. 
 29 
 
Figure 2.8: Representative CD spectra for α-helix (blue line), β-sheet (red line) and random coil (black 
line) (74)  
 
 
 
 
2.3 – Experimental  
 
 
2.3.1 - Materials  
 
The solvents for Solid Phase Peptide Synthesis were obtained from 
commercial suppliers. Amino acids, reagents and resins were acquired from Nova 
biochem and DMF for solid phase synthesis from Rathburn Chemicals.  
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2.3.2 – Methods 
 
2.3.2.1 – Peptide Synthesis 
 
 Peptides were synthesised using an automated peptide synthesizer (CEM liberty) 
and standard solid phase Fmoc-based protocols. MBHA rink amide was used to 
provide peptide amides and HBTU/DIPEA deployed for use as coupling reagents.  
Fmoc-protected amino acids (100x 4 µmol) with HBTU/DIPEA 
(dilauryphosphatidyglycerol) (100 x4 µmol: 0,16g / 67µl) were dissolved in 2 ml of 
DMF. The resin was mixed and then washed with DMF three times.  
 
 
2.3.2.2 - Fmoc and Alloc Deprotection 
 
To achieve Fmoc deprotection the resin was treated with 20% piperidine in 
DMF, after which the resin was washed three times with simple DMF. This 
procedure was repeated after each coupling. For Alloc deprotection, the resin was 
treated with tetrakis(PPh3)4Pd[0],(0,347g) dissolved in 4 ml of CHCl3:AcOH:DIPEA 
to the ratio of 38:1:1. This being a light sensitive reaction the reactor was wrapped in 
aluminium foil. After 12 hours, the resin was washed three times, in the first instance 
with 5% sodiumdiethyldthiocarbamate in DMF (5ml), then with DIPEA in DMF 
(5ml), and lastly, with DMF/DCM/DMF (5).    
 
 
 
 
 
 31 
2.3.2.3 - Cleavage of MBHA rink amide resin and removal of protection 
groups 
 
 All resins were cleaved using TFA/TIS/H2O 95:2,5:2,5 (5 ml) for 3 hours. After 
cleavage, the resin was filtered and washed with this mixture and with diethyl ether to 
precipitate a crude product. Peptide containing cysteines were cleaved with the use of 
TFA/EDT/H2O 95:2,5:2,5 (5 ml) 
 
2.3.3 - RP-HPLC 
 
Upon completion of the deprotection and cleavage processes, all the peptides 
were purified by analytical and semi-preparative RP-HPLC using a JASCO system and 
Vydac C18 analytical (5µm) and semi-preparative (5µm) columns, respectively. 
Running buffers A (95% H2O, 5% AcCN and 0,1% TFA) and B ( 95%AcCN, 5% H2O 
and 0,05%TFA) were used for10-60% B gradient over 46 min at 1 ml/min and 4.5 
ml/min. The peptides were characterized by MALDI-ToF and analytical HPLC.  
MS [ M+H] 
+
 : AC1 –  m/z 2643,52 ( calc), 2644,56 (found);  AC3 m/z 680,98 ( calc) , 
682,63 ( found) ; AC4 – m/z 944,32 ( calc) , 944,68 ( found) ; AC5 m/z 860,14 ( calc) , 
861,83 ( found) ; AC6 – m/z 596,79 ( calc) , 597,71 ( found) ; AC7 – m/z 595,7 ( calc) , 
598,47 ( found) ; AC8 – m/z 860,14 ( calc) , 860,78 ( found) ; AC9 m/z 944,33 ( calc) , 
945,93 ( found)  
 
2.3.4 - Circular Dichroism 
 
 Circular Dichroism spectroscopy was performed on a Chirascan plus. All 
measurements were taken in ellipticities( mdeg) and then converted into molar 
ellipticities (deg cm
2
 dmol res 
-1
) and normalized for the number of peptide bonds 
required. The stock solutions were prepared in water except those for the peptides with 
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cysteines, which were dissolved in aqueous 1mM TCEP. All aqueous solutions of the 
samples were prepared in filtered 10mM MOPS at pH 7.4.  
  
 
2.3.5 - Transmission Electron Microscopy 
 
 TEM was performed using a JEOL JEM 1200EX MKI microscope at the 
accelerating voltage of 100 kV and the images acquired with a fitted camera 
(MegaViewII). The sample (100 µM peptide concentrations) was prepared in 200 ml 
of 10 mM MOPS at pH 7.4 and incubated overnight at 20° C.  
 
 
2.3.6 - Antibacterial activity 
 
 Minimum inhibitory concentrations (MIC) were defined as the lowest peptide 
concentration in which no visible growth of a microorganism was observed after 24 
hours incubation at 37 C. MIC were determined by microdilution on Pseudomonas 
aeruginosa, Escherichia coli and Staphylococus aeruginosa. All tests were 
performed in duplicate. 
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Chapter 3 - Self-Assembly of peptide-amphiphile 
 
3.1-Introduction 
 
Biomolecular systems have been developed as biomaterials, which are generally 
designed from biological structural units such as peptides and proteins (5). The self-
assembly process is a powerful tool for the synthesis of these novel biomaterials, 
which are highly promising for medical research (5). Different classes of hybrid 
materials have been explored over the years. Peptide amphiphiles (PAs) are a 
particularly interesting and attractive class of self-assembling systems due to their 
potential for use in tissue engineering (58). The structures are characterized by a 
peptide sequence linked to an alkyl tail via the N-terminus. PAs have the capacity to 
organize into micelle-like cylindrical nanofibres in an aqueous solution owing to the 
intermolecular hydrogen bonding that is intrinsic to them (40). In micelle formation, 
alkyl chains form a hydrophobic core while the peptide segments are solvent-
exposed. The formation of nanofibre structures results in a high density of peptide 
epitopes and allows mineralization to occur. 
 PAs are biocompatible and biodegradable as they are composed of natural amino 
acids and lipids. The design principles for PAs have been extensively explored using 
a wide range of molecules with specific amino acid sequences (51).   
The α-helical structure is present in many proteins with important biological 
functions, such as antibiotics, transcription factors, muscle protein tropomyosin, 
tumour suppressor factors and cytoskeleton proteins. Helical domains often assemble 
into helical bundles or coiled coils. These are attracting a great deal of interest within 
the scientific community due to their potential and promise in the design of new 
peptide-based materials. Coiled coils and helices are characterized by heptad repeats 
of hydrophobic (H) and polar (P) amino acids in their sequences, PHPPHPP. 
Different antimicrobial peptides, many of which adopt helical conformations, 
have thus far been described. These peptides may be classified into several different 
groups according to their structure, origin and activity (75). Most of these peptides 
are cationic and can adopt amphipathic structures formed by the clustering of 
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hydrophobic and cationic residues (76). The mechanism of their biological activity is 
not yet fully understood, but peptides are predicted to bind negatively charged 
surfaces of Gram-negative and Gram-positive bacteria (75).  
In this chapter a helical design and a set of PAs with short peptide (3-5 amino 
acids) sequences attached to a hydrophobic domain are described. These peptides 
were characterized using molecular biophysics and biological testing. 
 
 
 
3.2-Results and discussion 
 
3.2.1 – α- helix – amphiphile structure 
 
AC1 peptide is built of two amino-acids types: hydrophobic (H) and polar 
(P). The sequence is linked to an aliphatic hydrophobic tail to promote micelle-like 
oligomerisaton (figure 3.1a). The hydrophobic residues in the sequence are 
alternating Ile and Leu residues, whilst cationic residues consist of Lys and Gln and 
polar residues of Ala.  
This construct was achieved by means of a flexible linker of two β-alanine 
residues inserted between the amino-acid sequence and the hydrophobic tail, lauric 
acid (C12), to provide a nonspecific micelle formation. In water amphiphile peptide 
self-assembles to create cylindrical micelles with alkyl tails occupying their centre 
(figure3.1b).  
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a) C12- βA-βA-KIAKLKAKIQKLKQKIAKLK 
 
 
b)  
 
Figure3.1: Lipoprotein design a) Peptide sequence used in the study b) schematic of micelle structure 
 
 
 
 
Circular dichroism (CD) spectroscopy with three different concentrations (50 µM, 
100 µM and 200 µM) at pH7 showed predominantly random coil conformations with 
some elements of a helical structure (figure 3.2). Figure 3.3 illustrates the CD spectra 
thermal denaturation (melting up to 90 C) for peptide AC1. Both spectra revealed 
negative peaks at 208 and 222 nm and a positive peak at 218 nm. 
Transmission Electron Microscopy (TEM) revealed fibrillar structures (figure 3.4). 
The fibres were found to have diameters of approximately 10-20 nm which at elevated 
temperatures increased to approximately 0,8μm diameters. This is consistent with the 
fact that assembly is driven primarily by the hydrophobic effect, and the peptide does 
not fold in a solution and in the absence of negatively charged bacterial membranes. 
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Figure 3.2: CD spectra at 20° C for AC1 at 50 µM (black line), 100µM (red line), 200 µ (blue line) in 10 
mM MOPS.     
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Figure 3.3: CD spectra for peptide AC1 at 10º C (black line) and at 90º C (red line) in 10 mM MOPS. 
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Figure 3.4: Negatively stained transmission electron micrographs of peptide AC1. Assembly conditions 
in 10 µM MOPS at pH 7.4, left overnight at 20° C (top) at melting (below)  
 
 
  
 
To reveal the antimicrobial properties of this peptide, a series of biological 
tests were performed. Peptide AC1 was tested against Gram-negative (Escherichia 
coli and Pseudomonas aeruginosa) and Gram-positive (Staphylococcus aureus) 
bacteria using microdilution assays. Figures 3.5, 3.6 and 3.7 illustrate the results of 
antimicrobial activity for the three bacteria tested.  
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Figure 3.5: Antimicrobial activity for Escherichia coli at 4.5 hours and 24 hours. Each value was done 
in duplicate. 
 
Figure 3.6: Antimicrobial activity for Pseudomonas aeruginosa at 4.5 hours and 24 hours. Each value 
was done in duplicate. 
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Figure3.7: Antimicrobial activity for Staphylococcus aureus at 4.5 hours and 24 hours. Each value was 
done in duplicate. 
 
 
 
 The peptide was noticeably active against all three bacteria. The Minimal 
Inhibitory Concentration (MIC) for Escherichia coli, Pseudomonas aeruginosa and 
Staphylococcus aureus was 12.5 µM, 6.25 µM and 25 µM, respectively. These 
results suggest that the peptide may have preference for targeting Gram-negative 
bacteria.  
 Upon comparison of eukaryotic and microbial membranes, the microbial 
membranes are found to be anionic. Therefore, the antimicrobial activity confirms 
the designed selectivity to permeabilize anionic membranes.    
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3.2.3 –Peptide-Amphiphile Structure 
 
 
In this work eight different PAs were designed and synthesized. The design was 
of an amphiphilic motif comprising a hydrophobic aliphatic tail, stearic acid (C18), 
and a hydrophilic peptide sequence. The peptides were designed to possess weak 
antimicrobial properties that may be enhanced by the self-assembly process; that is, 
through the contact of assembled structures with bacterial cells. The first series of 
peptide-amphiphile (AC 2-5) is shown in figure 3.8. In AC4 and AC5, two cysteine 
residues provide intermolecular thiol cross-linking between peptides to promote 
oligomerization.  
 
 
 
 
  
AC2 
C18QLR 
 
AC3 
C18Q(L)R 
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AC4 
C18CGCQLR 
 
AC5 
C18CGCQ(L)R 
 
 
 
Figure 3.8: Peptide –amphiphile types used in the study 
 
 
 
 
 
AC2 posed solubilisation difficulties, which hindered its purification and 
biophysical characterisation. CD spectroscopy revealed signals characteristic of β-
sheet conformations for AC4 peptide (figure 3.10). The spectra have a negative peak 
between 218 and 220 nm and a positive peak at 200 nm. However, the spectra for 
AC3 and AC5 were less resolved suggesting weak β-sheet or random coil 
conformations (Figure 3.9 and Figure 3.11).  
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Figure 3.9: CD spectra at 20ºC for peptide AC3 at 50 µM (black line), 100µM (red line), 200 µ (blue line). 
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Figure 3.10: CD spectra at 20ºC for peptide AC4 at 50 µM (black line), 100µM (red line), 200 µM (blue line). 
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Figure 3.11: CD spectra at 20ºC for peptide AC5 at 50 µM (black line), 100µM (red line), 200 µM (blue line). 
 
 
The formation of supramolecular structures was assessed by Transmission 
Electron Microscopy (TEM). In all cases, the PAs assembled into nanofibres but 
with different diameters and structures. Figure 3.12 and 3.13 shows the nanofibres of 
all peptide-amphiphile of this series. AC4 formed nanofibres with the diameters of 
approximately 5-10 nm and AC3 and AC5 assembled into extensive fibrillar 
networks of different morphologies. 
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Figure 3.12: Negatively stained transmission electron micrographs of peptide AC3. Assembly conditions in 10 µM 
MOPS at pH 7.4, left overnight 20° C. 
 
  
  
  
  
  
 
Figure 3.13: Negatively stained transmission electron micrographs of peptide AC4 (top) and peptide AC5 (below). 
Assembly conditions in 10 µM MOPS at pH 7.4, left overnight at 20° C. 
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All peptides were also tested against Gram-negative (Escherichia coli and 
Pseudomonas aeruginosa) and Gram-positive (Staphylococcus aureus) bacteria. As 
expected, weak antimicrobial activities were observed for all peptides using standard 
microdilution assays (table 1). 
 
Table 1: Minimal Inhibitory Concentration in μM 
 
 AC3 AC4 AC5 
Escherichia coli >100 >100 >100 
Pseudomonas 
aeruginosa 
>100 >100 >100 
Staphylococcus aureus >100 >100 >100 
  
 
 
The second series of PAs (AC6-AC9) was prepared to determine the effect of 
the length of the hydrophobic domain in fibre formation. Thus, the difference 
between this series and the first series is the length of the hydrophobic tail used. All 
peptides were linked at their N-termini with lauric (C12) acid to enable micelle 
formation (figure 3.14).  
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AC6 
C12QLR 
 
AC7 
C12Q(L)R 
 
 
AC8 
C12CGCQLR 
 
AC9 
C12CGCQ(L)R 
 
 
 
Figure 3.14: PA types used in the study. 
 
 
 
The secondary structure in aqueous solution was determinate by CD 
spectroscopy. In all cases, a main negative peak at 200 nm as for AC6, AC7, AC8 
and AC9 was observed suggesting a predominant random coil conformation (figures 
3.15-3.18). 
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TEM revealed random aggregates for all amphiphiles, which in some cases 
resembled fibrillar assemblies of very low densities (figures 3.19 and 3.20). This is 
consistent with the CD data and suggests weakened self-assembly properties of the 
first series as a result of shortened length of the aliphatic chain. 
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Figure 3.15: CD spectra at 20°C for AC6 at 50 µM (black line), 100µM (red line), 200 µM (blue line). 
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Figure 3.16: CD spectra at 20°C for peptide AC7 at 50 µM (black line), 100µM (red line), 200 µM (blue line). 
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Figure 3.17: CD spectra at 20°C for peptide AC8 at 50 µM (black line), 100µM (red line), 200 µM ( blue line ). 
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Figure 3.18: CD spectra at 20° C for peptide AC9 at 50 µM (black line), 100µM (red line), 200 µM (blue line). 
  
  
  
  
 
 
Figure 3.19: Negatively stained transmission electron micrographs of peptide AC6 (top) and peptide AC7 (below). 
Assembly conditions in 10 µM MOPS at pH 7.4, left overnight at 20° C. 
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Figure 3.20: Negatively stained transmission electron micrographs of peptide AC8 (top) and peptide AC 9 (below). 
Assembly conditions in 10 µM MOPS at pH 7.4, left overnight at 20° C. 
 
 
 
Antimicrobial tests revealed inconsistent results to judge the difference in 
behaviour between the peptides. None of the compounds except AC8 demonstrated 
visible activity against the bacterial cells using microdilution assays (Table 2), 
suggesting that all peptides possess weak antimicrobial activities for Minimal 
Inhibitory Concentrations (MICs) of ≤100 µM .  
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Table 2: Minimal Inhibitory Concentration in μM 
 
 AC6 AC7 AC8 AC9 
Escherichia coli >100 >100 100 >100 
Pseudomonas 
aeruginosa 
>100 >100 100 >100 
Staphylococcus 
aureus 
>100 >100 100 >100 
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General conclusion and future work 
 
 
Several examples of designer materials were described in this work. Three different 
series of peptide amphiphiles were generated. Specifically, AC1 was strongly antibacterial, 
adopted partially helical conformations and assembled into nanoscale fibrillar structures. It 
is strongly antimicrobial and its activity appears to be more efficient against Gram-
negative than against Gram-positive bacteria. A generic approach based on peptide self-
assembly to generate nanoscale fibrillar biomaterials was also described herein. Two 
different series of shorter designed lipopeptides were predominant in random coil 
conformations and some formed beta-sheet structures as judged by circular dichroism. The 
approach offers straight forward lipopeptide self-assembly templates leading to different 
fibrillar morphologies. A range of morphologies from elongated micron-sized fibrils to 
complex fibre networks were observed. Assembly appeared to be consistent with folding 
tendencies: more pronounced fibres were observed for more structured PAs. Biological 
properties of the building blocks (AC2-9) regarding potential antimicrobial activities were 
assessed. Individually, none of the blocks was strongly antimicrobial, which is consistent 
with the fact that antimicrobial properties have to be enhanced by fibrillar assembly and 
executed through direct contacts between fibre surfaces and the bacterial cell. This is 
currently being tested and constitutes future studies. The resulting fibrillar materials may 
be readily modified with different amino acids to provide different biological properties, 
such as cell adhesion support and biomineralization.  
This work demonstrates the feasibility of PA folding for self-assembled fibrillar 
materials that may find use in the design of novel biomaterials in applications for tissue 
engineering and biomedicine.
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